Hi DickyB, CF33-hNIS is used in both the MAST study and the CHECKvacc study.
MAST represents patients with METASTATIC ADVANCED SOLID TUMOURS, therefore by using the hNIS technology, the researchers can record the patients progressive scans and identify how advanced the metastatic cancer is, that has spread from its site of origin to other parts of the body.
Regards.
Hi DickyB, CF33-hNIS is used in both the MAST study and the...
-
- There are more pages in this discussion • 1,313 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.8¢ | $328.5K | 6.792M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 45 | 5443565 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 2171910 | 5 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |